ID   AT2B2_RAT               Reviewed;        1243 AA.
AC   P11506; Q63443;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   02-OCT-2024, entry version 211.
DE   RecName: Full=Plasma membrane calcium-transporting ATPase 2;
DE            Short=PMCA2;
DE            EC=7.2.2.10 {ECO:0000250|UniProtKB:Q01814, ECO:0000250|UniProtKB:Q9R0K7};
DE   AltName: Full=Plasma membrane calcium ATPase isoform 2;
DE   AltName: Full=Plasma membrane calcium pump isoform 2;
GN   Name=Atp2b2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=2837461; DOI=10.1016/s0021-9258(18)68354-1;
RA   Shull G.E., Greeb J.;
RT   "Molecular cloning of two isoforms of the plasma membrane Ca2+-transporting
RT   ATPase from rat brain. Structural and functional domains exhibit similarity
RT   to Na+,K+- and other cation transport ATPases.";
RL   J. Biol. Chem. 263:8646-8657(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1083-1243 (ISOFORMS WB/XB/YB/ZB), AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=1315513; DOI=10.1042/bj2830355;
RA   Adamo H.P., Penniston J.T.;
RT   "New Ca2+ pump isoforms generated by alternative splicing of rPMCA2 mRNA.";
RL   Biochem. J. 283:355-359(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1083-1243 (ISOFORMS WB/XB/YB/ZB), AND
RP   ALTERNATIVE SPLICING.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=8428948; DOI=10.1016/s0021-9258(18)53836-9;
RA   Keeton T.P., Burk S.E., Shull G.E.;
RT   "Alternative splicing of exons encoding the calmodulin-binding domains and
RT   C termini of plasma membrane Ca(2+)-ATPase isoforms 1, 2, 3, and 4.";
RL   J. Biol. Chem. 268:2740-2748(1993).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27 AND THR-1188,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1152 (ISOFORMS WA; WB AND
RP   WC), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1162 AND SER-1175
RP   (ISOFORM WB), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1161 (ISOFORMS
RP   WB AND YB), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1121 (ISOFORMS
RP   XA; XB AND XC), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1131 AND
RP   SER-1144 (ISOFORM XB), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1130
RP   (ISOFORMS XB AND ZB), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1138
RP   (ISOFORMS YA; YB AND YC), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-1147 AND SER-1148 (ISOFORM YB), PHOSPHORYLATION [LARGE SCALE ANALYSIS]
RP   AT SER-1107 (ISOFORMS ZA; ZB AND ZC), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-1116 AND SER-1117 (ISOFORM ZB), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: ATP-driven Ca(2+) ion pump involved in the maintenance of
CC       basal intracellular Ca(2+) levels in specialized cells of cerebellar
CC       circuit and vestibular and cochlear systems. Uses ATP as an energy
CC       source to transport cytosolic Ca(2+) ions across the plasma membrane to
CC       the extracellular compartment (By similarity). Has fast activation and
CC       Ca(2+) clearance rate suited to control fast neuronal Ca(2+) dynamics.
CC       At parallel fiber to Purkinje neuron synapse, mediates presynaptic
CC       Ca(2+) efflux in response to climbing fiber-induced Ca(2+) rise.
CC       Provides for fast return of Ca(2+) concentrations back to their resting
CC       levels, ultimately contributing to long-term depression induction and
CC       motor learning (By similarity). Plays an essential role in hearing and
CC       balance. In cochlear hair cells, shuttles Ca(2+) ions from stereocilia
CC       to the endolymph and dissipates Ca(2+) transients generated by the
CC       opening of the mechanoelectrical transduction channels. Regulates
CC       Ca(2+) levels in the vestibular system, where it contributes to the
CC       formation of otoconia (By similarity). In non-excitable cells,
CC       regulates Ca(2+) signaling through spatial control of Ca(2+) ions
CC       extrusion and dissipation of Ca(2+) transients generated by store-
CC       operated channels (By similarity). In lactating mammary gland, allows
CC       for the high content of Ca(2+) ions in the milk (By similarity).
CC       {ECO:0000250|UniProtKB:Q01814, ECO:0000250|UniProtKB:Q9R0K7}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + Ca(2+)(in) + H2O = ADP + Ca(2+)(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:18105, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29108, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456216; EC=7.2.2.10;
CC         Evidence={ECO:0000250|UniProtKB:Q01814,
CC         ECO:0000250|UniProtKB:Q9R0K7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18106;
CC         Evidence={ECO:0000250|UniProtKB:Q01814,
CC         ECO:0000250|UniProtKB:Q9R0K7};
CC   -!- SUBUNIT: Interacts with PDZD11. {ECO:0000250|UniProtKB:Q01814}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q01814};
CC       Multi-pass membrane protein {ECO:0000255}. Synapse
CC       {ECO:0000250|UniProtKB:Q9R0K7}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:Q01814}; Multi-pass membrane protein
CC       {ECO:0000255}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:Q01814}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=14;
CC         Comment=There is a combination of two alternatively spliced domains
CC         at N-terminal site A (W, X, Y and Z) and at C-terminal site C (A, B
CC         and C). So far the splice sites have only been studied independently.
CC         Experimental confirmation may be lacking for some isoforms.;
CC       Name=1;
CC         IsoId=P11506-13; Sequence=Displayed;
CC       Name=WB; Synonyms=AIIICI;
CC         IsoId=P11506-1; Sequence=VSP_038681, VSP_038682;
CC       Name=WA; Synonyms=AIIICII;
CC         IsoId=P11506-2; Sequence=VSP_000390;
CC       Name=XA; Synonyms=AIICII;
CC         IsoId=P11506-3; Sequence=VSP_000387, VSP_000390;
CC       Name=YA; Synonyms=AIIICII;
CC         IsoId=P11506-4; Sequence=VSP_000389, VSP_000390;
CC       Name=ZA; Synonyms=AICII;
CC         IsoId=P11506-5; Sequence=VSP_000388, VSP_000390;
CC       Name=XB; Synonyms=AIICI;
CC         IsoId=P11506-6; Sequence=VSP_000387, VSP_038681, VSP_038682;
CC       Name=YB; Synonyms=AIIICI;
CC         IsoId=P11506-7; Sequence=VSP_000389, VSP_038681, VSP_038682;
CC       Name=ZB; Synonyms=AICI;
CC         IsoId=P11506-8; Sequence=VSP_000388, VSP_038681, VSP_038682;
CC       Name=WC; Synonyms=AIIICIII;
CC         IsoId=P11506-9; Sequence=VSP_000391;
CC       Name=XC; Synonyms=AIICIII;
CC         IsoId=P11506-10; Sequence=VSP_000387, VSP_000391;
CC       Name=YC; Synonyms=AIIICIII;
CC         IsoId=P11506-11; Sequence=VSP_000389, VSP_000391;
CC       Name=ZC; Synonyms=AICIII;
CC         IsoId=P11506-12; Sequence=VSP_000388, VSP_000391;
CC       Name=2;
CC         IsoId=P11506-14; Sequence=VSP_000388;
CC   -!- TISSUE SPECIFICITY: Isoforms containing segment B are found in brain,
CC       uterus, liver and kidney and in low levels in other tissues. Isoforms
CC       containing segment W are found in kidney, uterus, and pancreas.
CC       Isoforms containing segment Y are found in pancreas and in low levels
CC       in brain and heart. Isoforms containing segment Z are found in brain
CC       and heart and isoforms containing segment X are found in low levels in
CC       brain. Isoforms containing segment A are found in low levels in heart
CC       and small intestine while isoforms containing segment C are found in
CC       testis and in low levels in other tissues.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIB subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03754; AAA74219.1; -; mRNA.
DR   EMBL; AH005430; AAB60703.1; -; Genomic_DNA.
DR   PIR; B28065; B28065.
DR   RefSeq; NP_036640.1; NM_012508.5. [P11506-14]
DR   AlphaFoldDB; P11506; -.
DR   SMR; P11506; -.
DR   BioGRID; 246403; 2.
DR   IntAct; P11506; 2.
DR   MINT; P11506; -.
DR   STRING; 10116.ENSRNOP00000045983; -.
DR   iPTMnet; P11506; -.
DR   PhosphoSitePlus; P11506; -.
DR   PaxDb; 10116-ENSRNOP00000063572; -.
DR   Ensembl; ENSRNOT00000095628.1; ENSRNOP00000090928.1; ENSRNOG00000030269.7. [P11506-13]
DR   Ensembl; ENSRNOT00065049048; ENSRNOP00065040228; ENSRNOG00065028357. [P11506-13]
DR   GeneID; 24215; -.
DR   KEGG; rno:24215; -.
DR   UCSC; RGD:2176; rat. [P11506-13]
DR   AGR; RGD:2176; -.
DR   CTD; 491; -.
DR   RGD; 2176; Atp2b2.
DR   eggNOG; KOG0204; Eukaryota.
DR   GeneTree; ENSGT00940000161461; -.
DR   InParanoid; P11506; -.
DR   OMA; IQHCKRA; -.
DR   OrthoDB; 847at2759; -.
DR   PhylomeDB; P11506; -.
DR   BRENDA; 7.2.2.10; 5301.
DR   Reactome; R-RNO-418359; Reduction of cytosolic Ca++ levels.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   PRO; PR:P11506; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000030269; Expressed in frontal cortex and 9 other cell types or tissues.
DR   ExpressionAtlas; P11506; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005929; C:cilium; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0032591; C:dendritic spine membrane; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:RGD.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0098684; C:photoreceptor ribbon synapse; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0030899; F:calcium-dependent ATPase activity; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0035254; F:glutamate receptor binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005388; F:P-type calcium transporter activity; IDA:RGD.
DR   GO; GO:1905059; F:P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0060088; P:auditory receptor cell stereocilium organization; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0021707; P:cerebellar granule cell differentiation; ISO:RGD.
DR   GO; GO:0021702; P:cerebellar Purkinje cell differentiation; ISO:RGD.
DR   GO; GO:0021692; P:cerebellar Purkinje cell layer morphogenesis; ISO:RGD.
DR   GO; GO:0021549; P:cerebellum development; ISO:RGD.
DR   GO; GO:0046068; P:cGMP metabolic process; ISO:RGD.
DR   GO; GO:0090102; P:cochlea development; ISO:RGD.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0048839; P:inner ear development; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0060113; P:inner ear receptor cell differentiation; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0007595; P:lactation; ISO:RGD.
DR   GO; GO:0040011; P:locomotion; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0003407; P:neural retina development; IEP:RGD.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:0070050; P:neuron cellular homeostasis; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045299; P:otolith mineralization; ISO:RGD.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0008361; P:regulation of cell size; ISO:RGD.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISS:UniProtKB.
DR   GO; GO:0042428; P:serotonin metabolic process; ISO:RGD.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   CDD; cd02081; P-type_ATPase_Ca_PMCA-like; 1.
DR   Gene3D; 3.40.1110.10; Calcium-transporting ATPase, cytoplasmic domain N; 1.
DR   Gene3D; 2.70.150.10; Calcium-transporting ATPase, cytoplasmic transduction domain A; 1.
DR   Gene3D; 1.20.1110.10; Calcium-transporting ATPase, transmembrane domain; 3.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1.
DR   InterPro; IPR022141; ATP_Ca_trans_C.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR006408; P-type_ATPase_IIB.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   NCBIfam; TIGR01517; ATPase-IIB_Ca; 1.
DR   NCBIfam; TIGR01494; ATPase_P-type; 3.
DR   PANTHER; PTHR24093; CATION TRANSPORTING ATPASE; 1.
DR   PANTHER; PTHR24093:SF377; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASE 2; 1.
DR   Pfam; PF12424; ATP_Ca_trans_C; 1.
DR   Pfam; PF13246; Cation_ATPase; 1.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 2.
DR   Pfam; PF00702; Hydrolase; 1.
DR   PRINTS; PR00119; CATATPASE.
DR   PRINTS; PR00121; NAKATPASE.
DR   SFLD; SFLDG00002; C1.7:_P-type_atpase_like; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF81653; Calcium ATPase, transduction domain A; 1.
DR   SUPFAM; SSF81665; Calcium ATPase, transmembrane domain M; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
DR   SUPFAM; SSF81660; Metal cation-transporting ATPase, ATP-binding domain N; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Ion transport; Magnesium; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Synapse; Translocase; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..1243
FT                   /note="Plasma membrane calcium-transporting ATPase 2"
FT                   /id="PRO_0000046216"
FT   TOPO_DOM        1..94
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        95..115
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        116..152
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        153..173
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        174..390
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        391..410
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        411..443
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        444..461
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        462..875
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        876..895
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        896..905
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        906..926
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        927..946
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        947..969
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        970..987
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        988..1009
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1010..1028
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1029..1050
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1051..1060
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1061..1082
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1083..1243
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          296..382
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1123..1140
FT                   /note="Calmodulin-binding subdomain A"
FT                   /evidence="ECO:0000250"
FT   REGION          1141..1150
FT                   /note="Calmodulin-binding subdomain B"
FT                   /evidence="ECO:0000250"
FT   REGION          1194..1243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..21
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        326..351
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        365..382
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1195..1243
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        499
FT                   /note="4-aspartylphosphate intermediate"
FT   BINDING         820
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         824
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0K7"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1139
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P20020"
FT   MOD_RES         1178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0K7"
FT   MOD_RES         1188
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1201
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0K7"
FT   MOD_RES         1211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01814"
FT   VAR_SEQ         303..347
FT                   /note="Missing (in isoform 2, isoform ZA, isoform ZB and
FT                   isoform ZC)"
FT                   /evidence="ECO:0000303|PubMed:2837461"
FT                   /id="VSP_000388"
FT   VAR_SEQ         303..333
FT                   /note="Missing (in isoform XA, isoform XB and isoform XC)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000387"
FT   VAR_SEQ         334..347
FT                   /note="Missing (in isoform YA, isoform YB and isoform YC)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000389"
FT   VAR_SEQ         1141..1243
FT                   /note="IRVVKAFRSSLYEGLEKPESRTSIHNFMAHPEFRIEDSQPHIPLIDDTDLEE
FT                   DAALKQNSSPPSSLNKNNSAIDSGINLTTDTSKSATSSSPGSPIHSLETSL -> IEVV
FT                   NTFKSGASFQGALRRQSSVTSQSQDVANLSSPSRVSLSNALSSPTSLPPAAAGQG (in
FT                   isoform WA, isoform XA, isoform YA and isoform ZA)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000390"
FT   VAR_SEQ         1141..1243
FT                   /note="IRVVKAFRSSLYEGLEKPESRTSIHNFMAHPEFRIEDSQPHIPLIDDTDLEE
FT                   DAALKQNSSPPSSLNKNNSAIDSGINLTTDTSKSATSSSPGSPIHSLETSL -> IEVV
FT                   NTFKSGASFQGALRRQSSVTSQSQDVANLSSPSRVSLSNALSSPTSLPPAAAGHPRREG
FT                   VP (in isoform WC, isoform XC, isoform YC and isoform ZC)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000391"
FT   VAR_SEQ         1141
FT                   /note="I -> IEVVNTFKSGASFQGALRRQSSVTSQSQDVASLSSPSRVSLSNALSS
FT                   PTSLPPAAAGI (in isoform WB, isoform XB, isoform YB and
FT                   isoform ZB)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_038681"
FT   VAR_SEQ         1201..1243
FT                   /note="Missing (in isoform WB, isoform XB, isoform YB and
FT                   isoform ZB)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_038682"
FT   MOD_RES         P11506-1:1152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-1:1161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-1:1162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-1:1175
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-2:1152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-3:1121
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-4:1138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-5:1107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-6:1121
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-6:1130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-6:1131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-6:1144
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-7:1138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-7:1147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-7:1148
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-7:1161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-8:1107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-8:1116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-8:1117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-8:1130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-9:1152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-10:1121
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-11:1138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P11506-12:1107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   1243 AA;  136811 MW;  1DC324836BFD5D59 CRC64;
     MGDMTNSDFY SKNQRNESSH GGEFGCSMEE LRSLMELRGT EAVVKIKETY GDTESICRRL
     KTSPVEGLPG TAPDLEKRKQ IFGQNFIPPK KPKTFLQLVW EALQDVTLII LEIAAIISLG
     LSFYHPPGES NEGCATAQGG AEDEGEAEAG WIEGAAILLS VICVVLVTAF NDWSKEKQFR
     GLQSRIEQEQ KFTVVRAGQV VQIPVAEIVV GDIAQIKYGD LLPADGLFIQ GNDLKIDESS
     LTGESDQVRK SVDKDPMLLS GTHVMEGSGR MVVTAVGVNS QTGIIFTLLG AGGEEEEKKD
     KKGVKKGDGL QLPAADGAAP ANAAGSANAS LVNGKMQDGS ADSSQSKAKQ QDGAAAMEMQ
     PLKSAEGGDA DDKKKANMHK KEKSVLQGKL TKLAVQIGKA GLVMSAITVI ILVLYFTVDT
     FVVNKKPWLT ECTPVYVQYF VKFFIIGVTV LVVAVPEGLP LAVTISLAYS VKKMMKDNNL
     VRHLDACETM GNATAICSDK TGTLTTNRMT VVQAYVGDVH YKEIPDPSSI NAKTLELLVN
     AIAINSAYTT KILPPEKEGA LPRQVGNKTE CGLLGFVLDL RQDYEPVRSQ MPEEKLYKVY
     TFNSVRKSMS TVIKMPDESF RMYSKGASEI VLKKCCKILS GAGEPRVFRP RDRDEMVKKV
     IEPMACDGLR TICVAYRDFP SSPEPDWDNE NDILNELTCI CVVGIEDPVR PEVPEAIRKC
     QRAGITVRMV TGDNINTARA IAIKCGIIHP GEDFLCLEGK EFNRRIRNEK GEIEQERIDK
     IWPKLRVLAR SSPTDKHTLV KGIIDSTHTE QRQVVAVTGD GTNDGPALKK ADVGFAMGIA
     GTDVAKEASD IILTDDNFSS IVKAVMWGRN VYDSISKFLQ FQLTVNVVAV IVAFTGACIT
     QDSPLKAVQM LWVNLIMDTF ASLALATEPP TETLLLRKPY GRNKPLISRT MMKNILGHAV
     YQLTLIFTLL FVGEKMFQID SGRNAPLHSP PSEHYTIIFN TFVMMQLFNE INARKIHGER
     NVFDGIFRNP IFCTIVLGTF AIQIVIVQFG GKPFSCSPLQ LDQWMWCIFI GLGELVWGQV
     IATIPTSRLK FLKEAGRLTQ KEEIPEEELN EDVEEIDHAE RELRRGQILW FRGLNRIQTQ
     IRVVKAFRSS LYEGLEKPES RTSIHNFMAH PEFRIEDSQP HIPLIDDTDL EEDAALKQNS
     SPPSSLNKNN SAIDSGINLT TDTSKSATSS SPGSPIHSLE TSL
//
